Calypso Biotech

Plan-les-ouates, Switzerland

Calypso Biotech is a biotechnology company that developes therapeutics for autoimmune diseases.

$9.5M raised

Sep 2021

Series A

Biotechnology Medical Pharmaceutical

Top Investors

Fountain Healthcare Partners Johnson & Johnson Innovation Inkef Gilde Healthcare M Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Calypso Biotech

How much funding has Calypso Biotech raised?

Calypso Biotech has raised $9.5M in total funding. The most recent round was Series A. The last funding was announced in September 2021.

Who are Calypso Biotech's investors?

Calypso Biotech's investors include Fountain Healthcare Partners, Johnson & Johnson Innovation, Inkef, Gilde Healthcare, M Ventures.

Where is Calypso Biotech headquartered?

Calypso Biotech is headquartered in Plan-les-ouates, Switzerland.

What does Calypso Biotech do?

Calypso Biotech is a biotechnology company that developes therapeutics for autoimmune diseases.

What stage is Calypso Biotech at?

Calypso Biotech is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 9, 2021.

MLA

"Calypso Biotech — Funding & Investors." VCBacked, September 9, 2021, https://www.vcbacked.co/company/calypso-biotech. Accessed July 1, 2026.

APA

VCBacked. (2021). Calypso Biotech — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/calypso-biotech

Wikipedia (cite web)

{{cite web |title=Calypso Biotech — Funding & Investors |url=https://www.vcbacked.co/company/calypso-biotech |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 9, 2021.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K